Total Payments
$142,649
2024 Payments
$44,588
Companies
66
Transactions
1,122
Medicare Patients
5,065
Medicare Billing
$1.0M
Payment Breakdown by Category
Consulting$63,350 (44.4%)
Food & Beverage$30,317 (21.3%)
Research$26,233 (18.4%)
Travel$16,744 (11.7%)
Other$5,797 (4.1%)
Education$208.85 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $63,350 | 37 | 44.4% |
| Food and Beverage | $30,317 | 1,005 | 21.3% |
| Unspecified | $26,233 | 2 | 18.4% |
| Travel and Lodging | $16,744 | 69 | 11.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,775 | 5 | 4.0% |
| Education | $208.85 | 3 | 0.1% |
| Entertainment | $21.79 | 1 | 0.0% |
Payments by Type
General
$116,416
1,120 transactions
Research
$26,233
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biosense Webster, Inc. | $50,282 | 97 | $0 (2024) |
| Eli Lilly and Company | $27,146 | 12 | $0 (2024) |
| Medical Device Business Services, Inc. | $20,427 | 37 | $0 (2021) |
| Abbott Laboratories | $7,881 | 61 | $0 (2024) |
| Medtronic, Inc. | $5,623 | 92 | $0 (2024) |
| Medtronic Vascular, Inc. | $5,004 | 71 | $0 (2020) |
| Boston Scientific Corporation | $4,580 | 77 | $0 (2024) |
| Wilson Cook Medical Incorporated | $3,600 | 2 | $0 (2024) |
| ATRICURE, INC. | $2,292 | 28 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $2,152 | 107 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,588 | 156 | Eli Lilly and Company ($27,146) |
| 2023 | $29,295 | 138 | Biosense Webster, Inc. ($22,699) |
| 2022 | $18,350 | 149 | Biosense Webster, Inc. ($10,678) |
| 2021 | $3,721 | 100 | Medical Device Business Services, Inc. ($800.00) |
| 2020 | $13,978 | 79 | Medical Device Business Services, Inc. ($8,429) |
| 2019 | $14,319 | 156 | Medical Device Business Services, Inc. ($7,601) |
| 2018 | $7,147 | 187 | Boston Scientific Corporation ($1,675) |
| 2017 | $11,251 | 157 | Medical Device Business Services, Inc. ($2,970) |
All Payment Transactions
1,122 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Structural Heart | ||||||
| 12/23/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $40.48 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.05 | General |
| Category: Cardiovascular | ||||||
| 12/16/2024 | Biosense Webster, Inc. | Thermocool SF (Device) | Travel and Lodging | In-kind items and services | $485.60 | General |
| Category: Therapeutic Catheters | ||||||
| 12/16/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Abbott Laboratories | AMPLATZER TORQVUE 45 X 45 (Device) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Structural Heart | ||||||
| 11/21/2024 | Abbott Laboratories | AMPLATZER TORQVUE 45 X 45 (Device) | Food and Beverage | In-kind items and services | $34.37 | General |
| Category: Structural Heart | ||||||
| 11/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $31.77 | General |
| 11/20/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: CONTRAST AGENT | ||||||
| 11/19/2024 | Medtronic, Inc. | NA (Device) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Ablation | ||||||
| 11/14/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $27.99 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Medtronic, Inc. | NA (Device) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Ablation | ||||||
| 11/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $23.14 | General |
| Category: Cardiology | ||||||
| 10/31/2024 | Medtronic, Inc. | PULSESELECT (Device) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Ablation | ||||||
| 10/29/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $31.36 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/22/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Pacemakers | ||||||
| 10/10/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Cardiology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ADULTS WITH ELEVATED LIPOPROTEIN(A) WHO HAVE ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR ARE AT RISK FOR A FIRST CARDIOVASCULAR EVENT - ACCLAIM-LP(A) | Eli Lilly and Company | $26,233 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,440 | 3,212 | $1.0M | $357,592 |
| 2022 | 30 | 1,292 | 2,672 | $649,630 | $243,501 |
| 2021 | 33 | 1,417 | 2,808 | $654,094 | $256,291 |
| 2020 | 26 | 916 | 1,488 | $404,910 | $152,133 |
Total Patients
5,065
Total Services
10,180
Medicare Billing
$1.0M
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 32 | 32 | $140,800 | $55,209 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 240 | 439 | $98,942 | $44,962 | 45.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 37 | 37 | $85,194 | $28,724 | 33.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 111 | 277 | $59,793 | $27,414 | 45.8% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 34 | 65 | $135,330 | $27,033 | 20.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 58 | 417 | $47,571 | $17,175 | 36.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 35 | 87 | $49,531 | $15,501 | 31.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 51 | 316 | $46,419 | $13,718 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 95 | $39,784 | $13,633 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 95 | 95 | $32,450 | $12,763 | 39.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 13 | 13 | $19,443 | $9,915 | 51.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 54 | 55 | $26,770 | $9,083 | 33.9% |
| 93653 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | Facility | 2023 | 13 | 13 | $22,271 | $9,028 | 40.5% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 16 | 16 | $20,589 | $8,841 | 42.9% |
| 33249 | Insertion of implantable defibrillator system | Facility | 2023 | 11 | 11 | $20,752 | $8,254 | 39.8% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 18 | 30 | $26,119 | $7,646 | 29.3% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 23 | 30 | $26,188 | $7,567 | 28.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 36 | 148 | $16,366 | $6,425 | 39.3% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 108 | $14,580 | $5,757 | 39.5% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 29 | 218 | $11,994 | $4,318 | 36.0% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 31 | 31 | $9,734 | $3,846 | 39.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 21 | 181 | $10,100 | $3,739 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 18 | $5,447 | $2,751 | 50.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 37 | 38 | $6,193 | $2,435 | 39.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 159 | 185 | $6,630 | $2,261 | 34.1% |
About Dr. Mark Lee, MD
Dr. Mark Lee, MD is a Internal Medicine healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2011. The National Provider Identifier (NPI) number assigned to this provider is 1487943510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Lee, MD has received a total of $142,649 in payments from pharmaceutical and medical device companies, with $44,588 received in 2024. These payments were reported across 1,122 transactions from 66 companies. The most common payment nature is "Consulting Fee" ($63,350).
As a Medicare-enrolled provider, Lee has provided services to 5,065 Medicare beneficiaries, totaling 10,180 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Clinical Cardiac Electrophysiology, Cardiovascular Disease
- Location Long Beach, CA
- Active Since 03/29/2011
- Last Updated 12/01/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1487943510
Products in Payments
- Carto 3 System (Device) $26,559
- EVOLUTION (Device) $4,603
- CARTO 3 (Device) $4,224
- MICRA (Device) $2,365
- AVEIR (Device) $2,105
- XARELTO (Drug) $2,040
- Thermocool SF (Device) $1,971
- DURATA (Device) $1,861
- EVERA MRI XT DR SURESCAN (Device) $1,523
- GENERAL THERAPIES (Device) $1,420
- ELIQUIS (Drug) $1,311
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $1,155
- ENTRESTO (Drug) $1,043
- Pacemakers (Device) $936.00
- Carto 3 (Device) $925.36
- Azure (Device) $857.55
- LifeVest (Device) $851.88
- WATCHMAN (Device) $827.14
- MULTAQ (Drug) $705.62
- RHYTHMIA (Device) $658.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Long Beach
Jennifer Connelly, D.o, D.O
Internal Medicine — Payments: $275,877
Internal Medicine $275,877
Dr. Mark Leibowitz, M.d, M.D
Internal Medicine — Payments: $103,211
Internal Medicine $103,211
Dr. Steven Appleby, Md, MD
Internal Medicine — Payments: $101,644
Internal Medicine $101,644
Dr. Milan Sheth, Md, MD
Internal Medicine — Payments: $71,682
Internal Medicine $71,682
Katya Corado, M.d, M.D
Internal Medicine — Payments: $30,357
Internal Medicine $30,357
Dr. Diane Chau, Md, MD
Internal Medicine — Payments: $26,560
Internal Medicine $26,560